POST-THROMBOTIC SYNDROME
Clinical trials for POST-THROMBOTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new POST-THROMBOTIC SYNDROME trials appear
Sign up with your email to follow new studies for POST-THROMBOTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for DVT patients: common arthritis drug may prevent lasting vein damage
Disease control Not yet recruitingThis study tests whether adding colchicine, an anti-inflammatory medicine, to standard blood thinners can reduce the risk of long-term vein damage (post-thrombotic syndrome) in people with a first-time deep vein clot in the leg. About 940 adults will receive either colchicine or …
Matched conditions: POST-THROMBOTIC SYNDROME
Phase: PHASE3 • Sponsor: Azienda Sanitaria Locale ASL 6, Livorno • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
ICU catheter clots: what happens after removal?
Knowledge-focused Not yet recruitingThis study watches 300 ICU patients to see how often blood clots from catheters remain after the catheter is taken out. It looks for risk factors and tracks whether the clot dissolves or causes problems like a lung clot. No new treatment is tested—just careful observation and ult…
Matched conditions: POST-THROMBOTIC SYNDROME
Sponsor: Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC